Cargando…

Pan-Cancer Prognostic Role and Targeting Potential of the Estrogen-Progesterone Axis

INTRODUCTION: Estrogen receptors (ESRs) and progesterone receptors (PGRs) are associated with the development and progression of various tumors. The feasibility of ESRs and PGRs as prognostic markers and therapeutic targets for multiple cancers was evaluated via pan-cancer analysis. METHODS: The pan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Yu-ting, Huang, Xing, Zhang, Gang, Jiang, Bo, Li, Cheng-jun, Wu, Zheng-sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311599/ https://www.ncbi.nlm.nih.gov/pubmed/34322374 http://dx.doi.org/10.3389/fonc.2021.636365

Ejemplares similares

Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance
por: Chen, Bi, et al.
Publicado: (2020)

Trends in estrogen and progesterone receptors in prostate cancer: a bibliometric analysis
por: Liao, Wenqiang, et al.
Publicado: (2023)

Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets
por: Zhang, Yinqi, et al.
Publicado: (2021)

The Prognostic Value and Immune Infiltration of USP10 in Pan-Cancer: A Potential Therapeutic Target
por: Gao, Dacheng, et al.
Publicado: (2022)

Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy
por: Jia, Yuting, et al.
Publicado: (2023)

Progesterone Receptor Expression in Meningiomas: Pathological and Prognostic Implications
por: Maiuri, Francesco, et al.
Publicado: (2021)

Prognostic Pathways Guide Drug Indications in Pan-Cancers
por: Meng, Fanlin, et al.
Publicado: (2022)

Pan-cancer analysis identified OAS1 as a potential prognostic biomarker for multiple tumor types
por: Jiang, Shan, et al.
Publicado: (2023)

A systemic pan-cancer analysis of MPZL3 as a potential prognostic biomarker and its correlation with immune infiltration and drug sensitivity in breast cancer
por: Huang, Renhong, et al.
Publicado: (2022)

Prognostic and Immunological Role of Gasdermin E in Pan-Cancer Analysis
por: Zhang, Zheng, et al.
Publicado: (2021)

ANXA2P2: A Potential Immunological and Prognostic Signature in Ovarian Serous Cystadenocarcinoma via Pan-Carcinoma Synthesis
por: Zhang, Yanna, et al.
Publicado: (2022)

A Comprehensive Prognostic and Immune Analysis of SLC41A3 in Pan-Cancer
por: Liu, Jun, et al.
Publicado: (2021)

Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy
por: Shen, Shuai, et al.
Publicado: (2020)

A systematic pan-cancer analysis of PXDN as a potential target for clinical diagnosis and treatment
por: Zhou, Xiaohu, et al.
Publicado: (2022)

SRSF3 Expression Serves as a Potential Biomarker for Prognostic and Immune Response in Pan-Cancer
por: Li, Zihua, et al.
Publicado: (2022)

Characterization of the Estrogen Response Helps to Predict Prognosis and Identify Potential Therapeutic Targets in Cholangiocarcinoma
por: Lu, Chenglin, et al.
Publicado: (2022)

The Potential of panHER Inhibition in Cancer
por: Wang, Xiaochun, et al.
Publicado: (2015)

Immunological role and prognostic value of SPARCL1 in pan-cancer analysis
por: He, Kangwei, et al.
Publicado: (2022)

Functional Implications of Estrogen and Progesterone Receptors Expression in Adenomyosis, Potential Targets for Endocrinological Therapy
por: Sztachelska, Maria, et al.
Publicado: (2022)

Immune Infiltration of MMP14 in Pan Cancer and Its Prognostic Effect on Tumors
por: Li, Minde, et al.
Publicado: (2021)

Pan-Cancer analysis shows that ACO2 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including hepatocellular carcinoma
por: Wang, Zhen, et al.
Publicado: (2022)

Comprehensive prognostic and immunological analysis of CCT2 in pan-cancer
por: Lv, Wenming, et al.
Publicado: (2022)

Machine Learning-Based Comparative Analysis of Pan-Cancer and Pan-Normal Tissues Identifies Pan-Cancer Tissue-Enriched circRNAs Related to Cancer Mutations as Potential Exosomal Biomarkers
por: Wang, Xuezhu, et al.
Publicado: (2021)

Pan-Immune-Inflammation Value: A New Prognostic Index in Operative Breast Cancer
por: Lin, Fei, et al.
Publicado: (2022)

The temporal reliability of serum estrogens, progesterone, gonadotropins, SHBG and urinary estrogen and progesterone metabolites in premenopausal women
por: Williams, Andrew E, et al.
Publicado: (2002)

Editorial: Targeting Estrogens in Cancer Care
por: Di Donato, Marzia
Publicado: (2022)

Pan-cancer analysis reveals that G6PD is a prognostic biomarker and therapeutic target for a variety of cancers
por: Zeng, Tao, et al.
Publicado: (2023)

HILPDA Is a Prognostic Biomarker and Correlates With Macrophage Infiltration in Pan-Cancer
por: Liu, Chengdong, et al.
Publicado: (2021)

Construction of a Prognostic Model for Hypoxia-Related LncRNAs and Prediction of the Immune Landscape in the Digestive System Pan-Cancer
por: He, Zikang, et al.
Publicado: (2022)

Prognostic and Immunological Role of FUN14 Domain Containing 1 in Pan-Cancer: Friend or Foe?
por: Yuan, Qingchen, et al.
Publicado: (2020)

Comprehensive Analysis and Experimental Validation of a Novel Estrogen/Progesterone-Related Prognostic Signature for Endometrial Cancer
por: Yu, Jing, et al.
Publicado: (2022)

Clinical Relevance and Prognostic Value of the Neuronal Protein Neuroligin 2 in Breast Cancer
por: Zhang, Gang, et al.
Publicado: (2021)

Estrogen, Progesterone and Epithelial Ovarian Cancer
por: Ho, Shuk-Mei
Publicado: (2003)

The Impact of Progesterone and Estrogen on the Tooth Mobility
por: Peruga, Małgorzata, et al.
Publicado: (2023)

Pan-Cancer Analysis of Potential Synthetic Lethal Drug Targets Specific to Alterations in DNA Damage Response
por: Das, Shaoli, et al.
Publicado: (2019)

INTERACTION OF ESTROGEN AND PROGESTERONE IN CHICK OVIDUCT DEVELOPMENT : II. Effects of Estrogen and Progesterone on Tubular Gland Cell Function
por: Oka, Takami, et al.
Publicado: (1969)

The MYC Paralog-PARP1 Axis as a Potential Therapeutic Target in MYC Paralog-Activated Small Cell Lung Cancer
por: Bian, Xing, et al.
Publicado: (2020)

Pan-Cancer Analysis of the Mitophagy-Related Protein PINK1 as a Biomarker for the Immunological and Prognostic Role
por: Zhu, Lizhe, et al.
Publicado: (2020)

WASF2 Serves as a Potential Biomarker and Therapeutic Target in Ovarian Cancer: A Pan-Cancer Analysis
por: Yang, Xiaofeng, et al.
Publicado: (2022)

SPRY4-AS1, A Novel Enhancer RNA, Is a Potential Novel Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma
por: Ye, Mu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hbjikksjq11426jitlcmaokn99